Surgical Removal of the Index Node Marked Using Magnetic Seed Localization to Assess Response to Neoadjuvant Immunotherapy in Patients With Stage III Melanoma

British Journal of Surgery - United States
doi 10.1002/bjs.11168
Full Text
Abstract

Available in full text

Categories
Surgery
Date
Authors
Publisher

Wiley

Related search

A Neoadjuvant Biochemotherapy Approach to Stage III Melanoma: Analysis of Surgical Outcomes

Immunotherapy
OncologyAllergyImmunology
2012English

Uncommon BRAF Mutations Associated With Durable Response to Immunotherapy in Patients With Metastatic Melanoma

Case Reports in Oncological Medicine
Oncology
2017English

Predictive and Prognostic Role of Metabolic Response in Patients With Stage III NSCLC Treated With Neoadjuvant Chemotherapy

Clinical Lung Cancer
Cancer ResearchOncologyRespiratory MedicinePulmonary
2020English

Defining T Cell States Associated With Response to Checkpoint Immunotherapy in Melanoma

Cell
BiochemistryGeneticsMolecular Biology
2019English

Association Between Circulating Tumor Cells and Prognosis in Patients With Stage III Melanoma With Sentinel Lymph Node Metastasis in a Phase III International Multicenter Trial

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2012English

Circulating Tumour DNA for Monitoring Treatment Response to Anti-Pd-1 Immunotherapy in Melanoma Patients

Acta Dermato-Venereologica
DermatologyMedicine
2017English

Preoperative BRAF Inhibition in Patients With Irresectable Locally Advanced Stage III Melanoma

Melanoma Management
DermatologyOncology
2018English

The Value of Pre Operative S-100b and SUV in Clinically Stage III Melanoma Patients Undergoing Therapeutic Lymph Node Dissection

European Journal of Surgical Oncology
MedicineOncologySurgery
2011English

The Influence of Postoperative Lymph Node Radiation Therapy on Overall Survival of Patients With Stage III Melanoma, a National Cancer Database Analysis

Melanoma Research
DermatologyCancer ResearchOncology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy